Live Breaking News & Updates on Sangamo Therapeutics Daily|Page 6
Stay updated with breaking news from Sangamo therapeutics daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Allspring Global Investments Holdings LLC grew its position in Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Free Report) by 278.8% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 46,408 shares of the biopharmaceutical company’s stock after acquiring an additional 34,157 shares during the period. Allspring Global […] ....
Sangamo Therapeutics (NASDAQ:SGMO – Free Report) had its price objective trimmed by HC Wainwright from $5.00 to $3.00 in a research note published on Monday morning, Benzinga reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for Sangamo Therapeutics’ Q4 2023 earnings at ($0.24) EPS, FY2023 […] ....
Shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Get Free Report) have received a consensus recommendation of “Hold” from the seven ratings firms that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to […] ....
Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the seven ratings firms that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating and six have assigned a buy rating to the company. The average 1 year […] ....
Analysts Set Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Target Price at $5.80 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.